Heart failure post-myocardial infarction: A review of the issues

Heart

Volumn 91, Issue SUPPL. 2, 2005, Pages

  Dargie, Henry ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANISTREPLASE; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GADOLINIUM; STATINE DERIVATIVE;

ANGIOCARDIOGRAPHY; AORTA BALLOON; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DEFIBRILLATOR; DEVICE; EARLY DIAGNOSIS; FIBRINOLYTIC THERAPY; HEALTH CARE SYSTEM; HEART ASSIST DEVICE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; SECONDARY PREVENTION; ST SEGMENT ELEVATION; STUNNED HEART MUSCLE; SURVIVAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIAC PACING, ARTIFICIAL; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; THROMBOLYTIC THERAPY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 17644403187     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.062018     Document Type: Conference Paper

References (15)

1. Yusuf S, Howken S, Ôunpuu S, et al. on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
3. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
4. Rawles J, on behalf of the GREAT group. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region early anistreplase trial (GREAT). J Am Coll Cardiol 1994;23:1-5.
5. Rawles J. GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis. Heart 2003;89:563-4.
6. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385-90.
7. Morrow DA, Cannon CP, Rifai N, et al. for the TACTICS-TIMI 18 investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286:2405-12.
8. Jernberg T, James S, Lindahl B, et al. Natriuretic peptides in unstable coronary artery disease. Eur Heart J 2004;25:1486-93.
9. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the multisite stimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-8.
10. Abraham WT, Fisher WG, Smith AL, et al. for the MIRACLE study group. Cardiac resynchronization in chronic heart failure. New Engl J Med 2002;346:1845-53.
11. Cleland JG, Daubert JC, Erdmann E, et al, CARE-HF study Steering Committee and Investigators. The CARE-HF study (cardiac resynchronisation in heart failure study): rationale, design and end-points. Eur J Heart Fail 2001;3:481-9.
12. Moss AJ, Zareba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
13. Bristow MR, Saxon LA, Boehmer J, et al, for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
14. Rose EA, Gelijns AC, Moskowitz AJ, et al, for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
15. McIntyre K, Stewart S, Capewell S, et al. Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol 2001;38:729-35.